aluates Reports

$ 0.0

Automative

Global Next Generation IVD Market Research Report 2026

Published Date: 2026-01-19

Report Code: QYRE-Auto-12K18669

Global Next Generation IVD Market Research Report 2024

BUY CHAPTERS

Global Next Generation IVD Market Research Report 2026

Code: QYRE-Auto-12K18669

Report

2026-01-19

Pages:145

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Danaher

Roche

Abbott

bioMérieux

Hologic Inc

Thermo Fisher Scientific

Shengxiang Bio

Coyote

Illumina Inc

Eurofins Scientific

BGI

Natera

Berry Genomics

Novogene

LabCorp

Pacific Biosciences

Azenta Life Sciences

Oxford Nanopore

Macrogen

Bio-Bio

Hangzhou Yousida

BGI Intelligence

Next Generation IVD Market Size

The global Next Generation IVD market was valued at US$ 49730 million in 2025 and is anticipated to reach US$ 89990 million by 2032, at a CAGR of 9.0% from 2026 to 2032.

Next Generation IVD Market

Next-Generation In Vitro Diagnostics (IVD) refers to advanced diagnostic tools and technologies designed to enhance the precision, speed, and accessibility of medical testing. These solutions leverage cutting-edge methodologies such as molecular diagnostics, artificial intelligence, microfluidics, and next-generation sequencing (NGS). The goal of next-gen IVDs is to enable earlier detection of diseases, personalized medicine, and better disease management, ultimately improving patient outcomes. Examples include real-time PCR, liquid biopsy platforms, and point-of-care devices that can deliver rapid, actionable results.

The North American market for Next Generation IVD is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Next Generation IVD is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Next Generation IVD in Autoimmune Diseases is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Next Generation IVD include Danaher, Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Next Generation IVD market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Next Generation IVD. The Next Generation IVD market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Next Generation IVD market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Next Generation IVD manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Next Generation IVD Market Report

Report Metric	Details
Report Name	Next Generation IVD Market
Accounted market size in 2025	US$ 49730 million
Forecasted market size in 2032	US$ 89990 million
CAGR	9.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Consumables Instruments
Segment by Application	Autoimmune Diseases Cardiology Diabetes Infectious Diseases Nephrology Oncology
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Danaher, Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, Hangzhou Yousida, Illumina, Eurofins Scientific, BGI, Natera, Berry Genomics, Novogene, BGI Intelligence, LabCorp, Pacific Biosciences, Azenta Life Sciences, Oxford Nanopore, Macrogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Next Generation IVD companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Next Generation IVD Market growing?

Ans: The Next Generation IVD Market witnessing a CAGR of 9.0% during the forecast period 2026-2032.

What is the Next Generation IVD Market size in 2032?

Ans: The Next Generation IVD Market size in 2032 will be US$ 89990 million.

Who are the main players in the Next Generation IVD Market report?

Ans: The main players in the Next Generation IVD Market are Danaher, Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Bio-Bio, B, Shengxiang Bio, COYOTE, Hangzhou Yousida, Illumina, Eurofins Scientific, BGI, Natera, Berry Genomics, Novogene, BGI Intelligence, LabCorp, Pacific Biosciences, Azenta Life Sciences, Oxford Nanopore, Macrogen

What are the Application segmentation covered in the Next Generation IVD Market report?

Ans: The Applications covered in the Next Generation IVD Market report are Autoimmune Diseases, Cardiology, Diabetes, Infectious Diseases, Nephrology, Oncology

What are the Type segmentation covered in the Next Generation IVD Market report?

Ans: The Types covered in the Next Generation IVD Market report are Consumables, Instruments

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Next Generation IVD Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Consumables

1.2.3 Instruments

1.3 Market by Application

1.3.1 Global Next Generation IVD Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Autoimmune Diseases

1.3.3 Cardiology

1.3.4 Diabetes

1.3.5 Infectious Diseases

1.3.6 Nephrology

1.3.7 Oncology

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Next Generation IVD Market Perspective (2021–2032)

2.2 Global Next Generation IVD Growth Trends by Region

2.2.1 Global Next Generation IVD Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Next Generation IVD Historic Market Size by Region (2021–2026)

2.2.3 Next Generation IVD Forecasted Market Size by Region (2027–2032)

2.3 Next Generation IVD Market Dynamics

2.3.1 Next Generation IVD Industry Trends

2.3.2 Next Generation IVD Market Drivers

2.3.3 Next Generation IVD Market Challenges

2.3.4 Next Generation IVD Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Next Generation IVD Players by Revenue

3.1.1 Global Top Next Generation IVD Players by Revenue (2021–2026)

3.1.2 Global Next Generation IVD Revenue Market Share by Players (2021–2026)

3.2 Global Top Next Generation IVD Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Next Generation IVD Revenue

3.4 Global Next Generation IVD Market Concentration Ratio

3.4.1 Global Next Generation IVD Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Next Generation IVD Revenue in 2025

3.5 Global Key Players of Next Generation IVD Head Offices and Areas Served

3.6 Global Key Players of Next Generation IVD, Products and Applications

3.7 Global Key Players of Next Generation IVD, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Next Generation IVD Breakdown Data by Type

4.1 Global Next Generation IVD Historic Market Size by Type (2021–2026)

4.2 Global Next Generation IVD Forecasted Market Size by Type (2027–2032)

5 Next Generation IVD Breakdown Data by Application

5.1 Global Next Generation IVD Historic Market Size by Application (2021–2026)

5.2 Global Next Generation IVD Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Next Generation IVD Market Size (2021–2032)

6.2 North America Next Generation IVD Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Next Generation IVD Market Size by Country (2021–2026)

6.4 North America Next Generation IVD Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Next Generation IVD Market Size (2021–2032)

7.2 Europe Next Generation IVD Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Next Generation IVD Market Size by Country (2021–2026)

7.4 Europe Next Generation IVD Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Next Generation IVD Market Size (2021–2032)

8.2 Asia-Pacific Next Generation IVD Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Next Generation IVD Market Size by Region (2021–2026)

8.4 Asia-Pacific Next Generation IVD Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Next Generation IVD Market Size (2021–2032)

9.2 Latin America Next Generation IVD Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Next Generation IVD Market Size by Country (2021–2026)

9.4 Latin America Next Generation IVD Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Next Generation IVD Market Size (2021–2032)

10.2 Middle East & Africa Next Generation IVD Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Next Generation IVD Market Size by Country (2021–2026)

10.4 Middle East & Africa Next Generation IVD Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Danaher

11.1.1 Danaher Company Details

11.1.2 Danaher Business Overview

11.1.3 Danaher Next Generation IVD Introduction

11.1.4 Danaher Revenue in Next Generation IVD Business (2021–2026)

11.1.5 Danaher Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Next Generation IVD Introduction

11.2.4 Roche Revenue in Next Generation IVD Business (2021–2026)

11.2.5 Roche Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Next Generation IVD Introduction

11.3.4 Abbott Revenue in Next Generation IVD Business (2021–2026)

11.3.5 Abbott Recent Development

11.4 bioMérieux

11.4.1 bioMérieux Company Details

11.4.2 bioMérieux Business Overview

11.4.3 bioMérieux Next Generation IVD Introduction

11.4.4 bioMérieux Revenue in Next Generation IVD Business (2021–2026)

11.4.5 bioMérieux Recent Development

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic Next Generation IVD Introduction

11.5.4 Hologic Revenue in Next Generation IVD Business (2021–2026)

11.5.5 Hologic Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Details

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Next Generation IVD Introduction

11.6.4 Thermo Fisher Scientific Revenue in Next Generation IVD Business (2021–2026)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Bio-Bio

11.7.1 Bio-Bio Company Details

11.7.2 Bio-Bio Business Overview

11.7.3 Bio-Bio Next Generation IVD Introduction

11.7.4 Bio-Bio Revenue in Next Generation IVD Business (2021–2026)

11.7.5 Bio-Bio Recent Development

11.8 B

11.8.1 B Company Details

11.8.2 B Business Overview

11.8.3 B Next Generation IVD Introduction

11.8.4 B Revenue in Next Generation IVD Business (2021–2026)

11.8.5 B Recent Development

11.9 Shengxiang Bio

11.9.1 Shengxiang Bio Company Details

11.9.2 Shengxiang Bio Business Overview

11.9.3 Shengxiang Bio Next Generation IVD Introduction

11.9.4 Shengxiang Bio Revenue in Next Generation IVD Business (2021–2026)

11.9.5 Shengxiang Bio Recent Development

11.10 COYOTE

11.10.1 COYOTE Company Details

11.10.2 COYOTE Business Overview

11.10.3 COYOTE Next Generation IVD Introduction

11.10.4 COYOTE Revenue in Next Generation IVD Business (2021–2026)

11.10.5 COYOTE Recent Development

11.11 Hangzhou Yousida

11.11.1 Hangzhou Yousida Company Details

11.11.2 Hangzhou Yousida Business Overview

11.11.3 Hangzhou Yousida Next Generation IVD Introduction

11.11.4 Hangzhou Yousida Revenue in Next Generation IVD Business (2021–2026)

11.11.5 Hangzhou Yousida Recent Development

11.12 Illumina

11.12.1 Illumina Company Details

11.12.2 Illumina Business Overview

11.12.3 Illumina Next Generation IVD Introduction

11.12.4 Illumina Revenue in Next Generation IVD Business (2021–2026)

11.12.5 Illumina Recent Development

11.13 Eurofins Scientific

11.13.1 Eurofins Scientific Company Details

11.13.2 Eurofins Scientific Business Overview

11.13.3 Eurofins Scientific Next Generation IVD Introduction

11.13.4 Eurofins Scientific Revenue in Next Generation IVD Business (2021–2026)

11.13.5 Eurofins Scientific Recent Development

11.14 BGI

11.14.1 BGI Company Details

11.14.2 BGI Business Overview

11.14.3 BGI Next Generation IVD Introduction

11.14.4 BGI Revenue in Next Generation IVD Business (2021–2026)

11.14.5 BGI Recent Development

11.15 Natera

11.15.1 Natera Company Details

11.15.2 Natera Business Overview

11.15.3 Natera Next Generation IVD Introduction

11.15.4 Natera Revenue in Next Generation IVD Business (2021–2026)

11.15.5 Natera Recent Development

11.16 Berry Genomics

11.16.1 Berry Genomics Company Details

11.16.2 Berry Genomics Business Overview

11.16.3 Berry Genomics Next Generation IVD Introduction

11.16.4 Berry Genomics Revenue in Next Generation IVD Business (2021–2026)

11.16.5 Berry Genomics Recent Development

11.17 Novogene

11.17.1 Novogene Company Details

11.17.2 Novogene Business Overview

11.17.3 Novogene Next Generation IVD Introduction

11.17.4 Novogene Revenue in Next Generation IVD Business (2021–2026)

11.17.5 Novogene Recent Development

11.18 BGI Intelligence

11.18.1 BGI Intelligence Company Details

11.18.2 BGI Intelligence Business Overview

11.18.3 BGI Intelligence Next Generation IVD Introduction

11.18.4 BGI Intelligence Revenue in Next Generation IVD Business (2021–2026)

11.18.5 BGI Intelligence Recent Development

11.19 LabCorp

11.19.1 LabCorp Company Details

11.19.2 LabCorp Business Overview

11.19.3 LabCorp Next Generation IVD Introduction

11.19.4 LabCorp Revenue in Next Generation IVD Business (2021–2026)

11.19.5 LabCorp Recent Development

11.20 Pacific Biosciences

11.20.1 Pacific Biosciences Company Details

11.20.2 Pacific Biosciences Business Overview

11.20.3 Pacific Biosciences Next Generation IVD Introduction

11.20.4 Pacific Biosciences Revenue in Next Generation IVD Business (2021–2026)

11.20.5 Pacific Biosciences Recent Development

11.21 Azenta Life Sciences

11.21.1 Azenta Life Sciences Company Details

11.21.2 Azenta Life Sciences Business Overview

11.21.3 Azenta Life Sciences Next Generation IVD Introduction

11.21.4 Azenta Life Sciences Revenue in Next Generation IVD Business (2021–2026)

11.21.5 Azenta Life Sciences Recent Development

11.22 Oxford Nanopore

11.22.1 Oxford Nanopore Company Details

11.22.2 Oxford Nanopore Business Overview

11.22.3 Oxford Nanopore Next Generation IVD Introduction

11.22.4 Oxford Nanopore Revenue in Next Generation IVD Business (2021–2026)

11.22.5 Oxford Nanopore Recent Development

11.23 Macrogen

11.23.1 Macrogen Company Details

11.23.2 Macrogen Business Overview

11.23.3 Macrogen Next Generation IVD Introduction

11.23.4 Macrogen Revenue in Next Generation IVD Business (2021–2026)

11.23.5 Macrogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Danaher

Roche

Abbott

bioMérieux

Hologic Inc

Thermo Fisher Scientific

Shengxiang Bio

Coyote

Illumina Inc

Eurofins Scientific

BGI

Natera

Berry Genomics

Novogene

LabCorp

Pacific Biosciences

Azenta Life Sciences

Oxford Nanopore

Macrogen

Bio-Bio

Hangzhou Yousida

BGI Intelligence

List of Tables

Table 1. Global Next Generation IVD Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Consumables

Table 3. Key Players of Instruments

Table 4. Global Next Generation IVD Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Next Generation IVD Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Next Generation IVD Market Size by Region (US$ Million), 2021–2026

Table 7. Global Next Generation IVD Market Share by Region (2021–2026)

Table 8. Global Next Generation IVD Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Next Generation IVD Market Share by Region (2027–2032)

Table 10. Next Generation IVD Market Trends

Table 11. Next Generation IVD Market Drivers

Table 12. Next Generation IVD Market Challenges

Table 13. Next Generation IVD Market Restraints

Table 14. Global Next Generation IVD Revenue by Players (US$ Million), 2021–2026

Table 15. Global Next Generation IVD Market Share by Players (2021–2026)

Table 16. Global Top Next Generation IVD Players by Tier (Tier 1, Tier 2, and Tier 3), based on Next Generation IVD Revenue, 2025

Table 17. Ranking of Global Top Next Generation IVD Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Next Generation IVD Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Next Generation IVD, Headquarters and Area Served

Table 20. Global Key Players of Next Generation IVD, Products and Applications

Table 21. Global Key Players of Next Generation IVD, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Next Generation IVD Market Size by Type (US$ Million), 2021–2026

Table 24. Global Next Generation IVD Revenue Market Share by Type (2021–2026)

Table 25. Global Next Generation IVD Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Next Generation IVD Revenue Market Share by Type (2027–2032)

Table 27. Global Next Generation IVD Market Size by Application (US$ Million), 2021–2026

Table 28. Global Next Generation IVD Revenue Market Share by Application (2021–2026)

Table 29. Global Next Generation IVD Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Next Generation IVD Revenue Market Share by Application (2027–2032)

Table 31. North America Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Next Generation IVD Market Size by Country (US$ Million), 2021–2026

Table 33. North America Next Generation IVD Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Next Generation IVD Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Next Generation IVD Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Next Generation IVD Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Next Generation IVD Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Next Generation IVD Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Next Generation IVD Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Next Generation IVD Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Next Generation IVD Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Next Generation IVD Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Next Generation IVD Market Size by Country (US$ Million), 2027–2032

Table 46. Danaher Company Details

Table 47. Danaher Business Overview

Table 48. Danaher Next Generation IVD Product

Table 49. Danaher Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 50. Danaher Recent Development

Table 51. Roche Company Details

Table 52. Roche Business Overview

Table 53. Roche Next Generation IVD Product

Table 54. Roche Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 55. Roche Recent Development

Table 56. Abbott Company Details

Table 57. Abbott Business Overview

Table 58. Abbott Next Generation IVD Product

Table 59. Abbott Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 60. Abbott Recent Development

Table 61. bioMérieux Company Details

Table 62. bioMérieux Business Overview

Table 63. bioMérieux Next Generation IVD Product

Table 64. bioMérieux Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 65. bioMérieux Recent Development

Table 66. Hologic Company Details

Table 67. Hologic Business Overview

Table 68. Hologic Next Generation IVD Product

Table 69. Hologic Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 70. Hologic Recent Development

Table 71. Thermo Fisher Scientific Company Details

Table 72. Thermo Fisher Scientific Business Overview

Table 73. Thermo Fisher Scientific Next Generation IVD Product

Table 74. Thermo Fisher Scientific Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 75. Thermo Fisher Scientific Recent Development

Table 76. Bio-Bio Company Details

Table 77. Bio-Bio Business Overview

Table 78. Bio-Bio Next Generation IVD Product

Table 79. Bio-Bio Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 80. Bio-Bio Recent Development

Table 81. B Company Details

Table 82. B Business Overview

Table 83. B Next Generation IVD Product

Table 84. B Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 85. B Recent Development

Table 86. Shengxiang Bio Company Details

Table 87. Shengxiang Bio Business Overview

Table 88. Shengxiang Bio Next Generation IVD Product

Table 89. Shengxiang Bio Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 90. Shengxiang Bio Recent Development

Table 91. COYOTE Company Details

Table 92. COYOTE Business Overview

Table 93. COYOTE Next Generation IVD Product

Table 94. COYOTE Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 95. COYOTE Recent Development

Table 96. Hangzhou Yousida Company Details

Table 97. Hangzhou Yousida Business Overview

Table 98. Hangzhou Yousida Next Generation IVD Product

Table 99. Hangzhou Yousida Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 100. Hangzhou Yousida Recent Development

Table 101. Illumina Company Details

Table 102. Illumina Business Overview

Table 103. Illumina Next Generation IVD Product

Table 104. Illumina Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 105. Illumina Recent Development

Table 106. Eurofins Scientific Company Details

Table 107. Eurofins Scientific Business Overview

Table 108. Eurofins Scientific Next Generation IVD Product

Table 109. Eurofins Scientific Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 110. Eurofins Scientific Recent Development

Table 111. BGI Company Details

Table 112. BGI Business Overview

Table 113. BGI Next Generation IVD Product

Table 114. BGI Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 115. BGI Recent Development

Table 116. Natera Company Details

Table 117. Natera Business Overview

Table 118. Natera Next Generation IVD Product

Table 119. Natera Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 120. Natera Recent Development

Table 121. Berry Genomics Company Details

Table 122. Berry Genomics Business Overview

Table 123. Berry Genomics Next Generation IVD Product

Table 124. Berry Genomics Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 125. Berry Genomics Recent Development

Table 126. Novogene Company Details

Table 127. Novogene Business Overview

Table 128. Novogene Next Generation IVD Product

Table 129. Novogene Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 130. Novogene Recent Development

Table 131. BGI Intelligence Company Details

Table 132. BGI Intelligence Business Overview

Table 133. BGI Intelligence Next Generation IVD Product

Table 134. BGI Intelligence Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 135. BGI Intelligence Recent Development

Table 136. LabCorp Company Details

Table 137. LabCorp Business Overview

Table 138. LabCorp Next Generation IVD Product

Table 139. LabCorp Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 140. LabCorp Recent Development

Table 141. Pacific Biosciences Company Details

Table 142. Pacific Biosciences Business Overview

Table 143. Pacific Biosciences Next Generation IVD Product

Table 144. Pacific Biosciences Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 145. Pacific Biosciences Recent Development

Table 146. Azenta Life Sciences Company Details

Table 147. Azenta Life Sciences Business Overview

Table 148. Azenta Life Sciences Next Generation IVD Product

Table 149. Azenta Life Sciences Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 150. Azenta Life Sciences Recent Development

Table 151. Oxford Nanopore Company Details

Table 152. Oxford Nanopore Business Overview

Table 153. Oxford Nanopore Next Generation IVD Product

Table 154. Oxford Nanopore Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 155. Oxford Nanopore Recent Development

Table 156. Macrogen Company Details

Table 157. Macrogen Business Overview

Table 158. Macrogen Next Generation IVD Product

Table 159. Macrogen Revenue in Next Generation IVD Business (US$ Million), 2021–2026

Table 160. Macrogen Recent Development

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

Table 164. Authors List of This Report

List of Figures

Figure 1. Next Generation IVD Picture

Figure 2. Global Next Generation IVD Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Next Generation IVD Market Share by Type: 2025 vs 2032

Figure 4. Consumables Features

Figure 5. Instruments Features

Figure 6. Global Next Generation IVD Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Next Generation IVD Market Share by Application: 2025 vs 2032

Figure 8. Autoimmune Diseases Case Studies

Figure 9. Cardiology Case Studies

Figure 10. Diabetes Case Studies

Figure 11. Infectious Diseases Case Studies

Figure 12. Nephrology Case Studies

Figure 13. Oncology Case Studies

Figure 14. Next Generation IVD Report Years Considered

Figure 15. Global Next Generation IVD Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 16. Global Next Generation IVD Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 17. Global Next Generation IVD Market Share by Region: 2025 vs 2032

Figure 18. Global Next Generation IVD Market Share by Players in 2025

Figure 19. Global Next Generation IVD Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Next Generation IVD Revenue in 2025

Figure 21. North America Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. North America Next Generation IVD Market Share by Country (2021–2032)

Figure 23. United States Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Canada Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. Europe Next Generation IVD Market Share by Country (2021–2032)

Figure 27. Germany Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. France Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. U.K. Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Italy Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Russia Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Ireland Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Asia-Pacific Next Generation IVD Market Share by Region (2021–2032)

Figure 35. China Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Japan Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. South Korea Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Southeast Asia Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. India Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Australia & New Zealand Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Latin America Next Generation IVD Market Share by Country (2021–2032)

Figure 43. Mexico Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Brazil Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Middle East & Africa Next Generation IVD Market Share by Country (2021–2032)

Figure 47. Israel Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Saudi Arabia Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. UAE Next Generation IVD Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Danaher Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 51. Roche Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 52. Abbott Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 53. bioMérieux Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 54. Hologic Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 56. Bio-Bio Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 57. B Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 58. Shengxiang Bio Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 59. COYOTE Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 60. Hangzhou Yousida Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 61. Illumina Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 62. Eurofins Scientific Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 63. BGI Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 64. Natera Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 65. Berry Genomics Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 66. Novogene Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 67. BGI Intelligence Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 68. LabCorp Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 69. Pacific Biosciences Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 70. Azenta Life Sciences Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 71. Oxford Nanopore Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 72. Macrogen Revenue Growth Rate in Next Generation IVD Business (2021–2026)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global In Vitro Diagnostics IVDs Medical Device Market Research Report 2025

Global IVD In Vitro Diagnostics Products Market Research Report 2024

In Vitro Diagnostic IVD Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnostic IVD Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular in Vitro Diagnostics Market Research Report 2024

Global High end Products For In Vitro Diagnostics Market Research Report 2024

In Vitro Diagnostics IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vitro Diagnostics IVD Pumps Market Research Report 2024

Global IVD Market Research Report 2024

Global Sample Preparation System for IVD In Vitro Diagnostic Market Research Report 2025

Global In Vitro Diagnostics IVDs Products Contract Manufacturing Market Research Report 2024

Global In Vitro Diagnostics IVD Devices Market Insights Forecast to 2030

In Vitro Diagnostic Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In Vitro Diagnosis IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Infectious Disease Testing Using PCR for IVD Market

Global IVD Infectious Diseases Market Insights Forecast to 2030

Global Urine in Vitro Diagnostics Market Research Report 2024

Lab Automation for In vitro Diagnostics Market

Global Biochemical in Vitro Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions